Richard A Young

CIK 1490283 · last filed 2026-08-05

Richard A Young is a corporate insider who has filed 56 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing shows the insider bought $27.0K of CAMP on Aug 5, 2026. Across all open-market trades the lifetime net is −$1.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $730.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$730.6K

Companies

Total Filings

Lifetime Open-Market Net

-$1.75M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

C/O SYROS PHARMACEUTICALS, INC.
620 MEMORIAL DRIVE SUITE 300
CAMBRIDGE, MA 02139

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CAMP	Director	186,388	$3.92	$730.6K	$52.0K	5	2026-08-05
Syros Pharmaceuticals, Inc. (SYRS) Delisted	Director	10,667	$0.00	$4	-$1.35M	29	2024-09-18
Omega Therapeutics, Inc. (OMGA) Delisted	Director	739,118	$0.14	$105.4K	-$440.0K	9	2024-06-21
Viskase Holdings, Inc. (ENZN) Delisted	Director	302	—	—	-$13.8K	8	2013-01-04

Recent Filings

56 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-08-05	CAMP	Buy (P)	+16,378	$27.0K	EDGAR
2026-06-12	CAMP	Grant (A)	—	$0	EDGAR
2025-09-11	CAMP	Buy (P)	+15,151	$25.0K	EDGAR
2025-06-27	CAMP	Grant (A)	—	$0	EDGAR
2025-02-05	—	Notice (144)	−550,000	-$100.0K	EDGAR
2024-12-10	—	Notice (144)	−6,667	-$1.5K	EDGAR
2024-10-15	CAMP	Conv (C)	+8,917	$0	EDGAR
2024-09-18	Syros Pharmaceuticals, Inc. (SYRS) Delisted	Exer (M)	+2,667	$0	EDGAR
2024-07-02	Syros Pharmaceuticals, Inc. (SYRS) Delisted	Sell (S)	−34,837	-$178.4K	EDGAR
2024-06-28	—	Notice (144)	−34,837	-$199.3K	EDGAR

Showing 1–10 of 56

Page 1 of 6 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.